Mifepristone science: What to know about the abortion pill - Washington Examiner

Contributing sentiments towards policy:

57% : The FDA's warning label on mifepristone estimates that between 2.9% and 4.6% of self-managed abortion patients will seek emergency medical treatment due to complications, including severe and sustained bleeding or potentially fatal infections.
52% : With nearly 643,000 medication abortions in 2023, that's approximately 20,000 emergency visits for self-managed abortion patients.
43% : Using data from states that cover abortion through Medicaid, the studies found that a patient was 22% more likely to visit the ER for any reason after a chemical abortion compared to a surgical procedure.
42% : Two papers written by James Studnicki and colleagues affiliated with the American Association of Pro-Life Obstetricians and Gynecologists were retracted in February by Sage Journals, a major academic publishing house.
22% : Mifepristone was entirely banned in the United States from 1989 until 1993, when then-President Bill Clinton ordered the Department of Health and Human Services to begin investigations into the drug's safety and efficacy for medication abortions in early pregnancy.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.